IRIS
FRIES, Walter
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.378
NA - Nord America 7.694
AS - Asia 5.214
SA - Sud America 1.838
AF - Africa 142
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 8
Totale 25.295
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.550
RU - Federazione Russa 5.194
SG - Singapore 2.405
BR - Brasile 1.581
CN - Cina 1.361
SE - Svezia 1.212
IE - Irlanda 1.182
HK - Hong Kong 630
FR - Francia 562
DE - Germania 542
IT - Italia 434
UA - Ucraina 382
GB - Regno Unito 312
VN - Vietnam 275
FI - Finlandia 232
PL - Polonia 116
IN - India 101
AR - Argentina 87
BD - Bangladesh 79
MX - Messico 56
CA - Canada 51
TR - Turchia 48
ZA - Sudafrica 44
NL - Olanda 43
EC - Ecuador 41
AT - Austria 40
IQ - Iraq 39
JP - Giappone 39
CO - Colombia 35
MA - Marocco 29
UZ - Uzbekistan 27
ES - Italia 26
BE - Belgio 25
ID - Indonesia 25
VE - Venezuela 22
PY - Paraguay 21
CL - Cile 20
PK - Pakistan 19
AZ - Azerbaigian 18
KZ - Kazakistan 16
AU - Australia 15
KE - Kenya 14
PE - Perù 14
JO - Giordania 13
SA - Arabia Saudita 13
NP - Nepal 12
PH - Filippine 11
TN - Tunisia 11
AL - Albania 10
UY - Uruguay 10
IL - Israele 9
AE - Emirati Arabi Uniti 8
MY - Malesia 8
NI - Nicaragua 8
DO - Repubblica Dominicana 7
EG - Egitto 7
LT - Lituania 7
SN - Senegal 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
GE - Georgia 6
NO - Norvegia 6
OM - Oman 6
RS - Serbia 6
BO - Bolivia 5
CR - Costa Rica 5
GA - Gabon 5
JM - Giamaica 5
KR - Corea 5
LB - Libano 5
LV - Lettonia 5
NZ - Nuova Zelanda 5
PA - Panama 5
PS - Palestinian Territory 5
RO - Romania 5
SY - Repubblica araba siriana 5
AO - Angola 4
BY - Bielorussia 4
DZ - Algeria 4
IR - Iran 4
KG - Kirghizistan 4
LK - Sri Lanka 4
XK - ???statistics.table.value.countryCode.XK??? 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BH - Bahrain 3
EE - Estonia 3
ET - Etiopia 3
EU - Europa 3
GR - Grecia 3
GT - Guatemala 3
KW - Kuwait 3
TW - Taiwan 3
AM - Armenia 2
BW - Botswana 2
CI - Costa d'Avorio 2
GY - Guiana 2
HN - Honduras 2
LU - Lussemburgo 2
MD - Moldavia 2
Totale 25.273
Salva come PNG Salva come JPEG
Città #
Moscow 1.594
Singapore 1.333
Dublin 1.178
Ashburn 1.014
Chandler 953
Dallas 797
Jacksonville 765
Hong Kong 629
Nyköping 509
Beijing 450
San Jose 324
Princeton 220
The Dalles 212
Lauterbourg 204
Dearborn 191
Cambridge 184
Los Angeles 177
Des Moines 174
Medford 143
Messina 139
São Paulo 128
Buffalo 122
Lancaster 117
Boardman 113
Munich 105
Ho Chi Minh City 99
Ann Arbor 94
Warsaw 94
Woodbridge 69
Frankfurt am Main 61
Redondo Beach 60
Jinan 58
Tianjin 57
Rio de Janeiro 56
Hanoi 54
Wilmington 52
Bremen 50
Shenyang 49
Guangzhou 48
Belo Horizonte 43
San Mateo 42
New York 40
Orem 40
Seattle 38
Nuremberg 36
Tokyo 35
Turku 35
Chennai 29
Santa Clara 29
Brooklyn 28
Zhengzhou 28
Houston 27
Curitiba 26
Hebei 26
London 26
Brasília 25
Council Bluffs 25
Shenzhen 25
Brussels 24
Ningbo 24
Vienna 24
Nanjing 23
Campinas 22
Tashkent 22
Amsterdam 20
Catania 20
Denver 19
Haikou 19
San Francisco 19
Shanghai 19
Stockholm 19
Dhaka 18
Hangzhou 18
Helsinki 18
Baghdad 17
Changsha 17
Johannesburg 17
Porto Alegre 17
Washington 17
Baku 16
Boston 16
Chicago 15
Düsseldorf 15
Hyderabad 15
Manchester 15
Atlanta 14
Bogotá 14
Jiaxing 14
Poplar 14
Taizhou 14
Mexico City 13
Milan 13
Nanchang 13
Fortaleza 12
Guayaquil 12
Osasco 12
Phoenix 12
Quito 12
Ribeirão Preto 12
Rome 12
Totale 13.977
Salva come PNG Salva come JPEG
Nome #
A protective effect of the synthetic coumarine derivative cloricromene on DNB-colitis in the rat. 210
Diagnostic accuracy of faecal calprotectin in a symptom-based algorithm for early diagnosis of inflammatory bowel disease adjusting for differential verification bias using a Bayesian approach 203
Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis. 191
Optical coherence tomography evaluation of ulcerative colitis: The patterns and the comparison with histology 189
A protective effect of the synthetic coumarine derivative Cloricromene against DNB-colitis in the rat 185
A propensity score-matched comparison of infliximab and adalimumab in TNF-α inhibitors naïve and non-naïve patients with Crohn's disease: real-life data from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD) 181
Association between inflammatory bowel disease and sarcoidosis. Report of two cases and review of the literature 180
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study. 175
Alexithymia and inflammatory bowel disease: A systematic review 173
Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease. 172
A three year pilo study with 1,25 dihydroxyvitamin D, calcium and calcitonin for severe osteodystrophy in primary biliary cirrhosis 171
Azathioprine/6-Mercaptopurine in the treatment of inflammatory bowel disease (IBD)- A single centre experience. 170
Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project 167
OCT Performance in the Diagnosis of Ulcerative Colitis 165
Cancer risk in inflammatory bowel disease: a 6-year prospective multicenter nested case-control IG-IBD study 165
Age is a Risk Factor for Severe Infections and Mortality in Patients given Anti-Tumor Necrosis Factor Therapy for Inflammatory bowel disease. 162
Oral beclomethasone diproprionate in pediatric active ulcerative colitis: a comparison trial with mesalazine. 157
Combined approach with biologics and surgery for entero-cutaneous fistulas in Crohn’s disease 157
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab 157
Response evaluation and safety of thiopurines in the treatment of inflammatory bowel diseases (IBD): safety and response evaluation. 156
Azathioprine/6-Mercaptopurine in the treatment of inflammatory bowel disease (IBD)- A single centre experience 155
Fecal calprotectin correlates with intestinal permeabilità (IP) in patients with Crohn’s disease. 154
Adalimumab in Crohn's Disease: Tips and Tricks After 5 Years of Clinical Experience 154
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience. 153
Direct oral anticoagulants increase the risk of anaemia and hospitalization in IBD patients with active intestinal disease 153
Negative emotions in irritable bowel syndrome: which differences among IBS subtypes? 151
DWI ratios: New indexes for Crohn's disease activity at magnetic resonance enterography? 149
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study 149
Effectiveness of Ustekinumab on Crohn‘s Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD) 149
Anti-TNF Therapy in Elderly People in IBD: An Italian Multicentre Survey. 148
H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biologics. 147
A prospective comparison between CT enterography and MR enterography (MRE) in ileo-colonic Crohn’s disease: a single-center experience. 146
A “real life” experience of infliximab use for Crohn’s disease in southern Italy 144
Gastric permeability of sucrose is increased in portal hypertensive gastropathy. 144
Association between previously identified disease loci at chr12q15 and chr1p36 and UC in Italian population 144
Guide to magnetic resonance in Crohn's disease: from common findings to the more rare complicances. 144
Thiopurine treatment in inflammatory bowel disease: response predictors, safety and withdrawal in follow-up. 143
A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis 143
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study 142
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease after Ileocolonic Resection 141
Analisi molecolare dei geni TLR4 e CARD15/NOD2 in pazienti affetti da malattie infiammatorie croniche intestinali: dati preliminari in una popolazione del sud Italia 140
Dysfunctional metacognitive beliefs and gastrointestinal disorders. Beyond an ‘organic’/‘functional’ categorization in the clinical practice 140
Metacognitions and basic emotions in patients with irritable bowel syndrome and inflammatory bowel disease 140
Hemophagocytic lymphohistiocytic (HLH) syndrome in IBD patients treated with thiopurines – a case series 139
Adalimumab In Active Ulcerative Colitis: A “Real-Life” Observational Study on behalf of the Italian Group for the study of Inflammatory Bowel Disease. 139
Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD “AGED study” 139
The aged gut in inflammatory bowel diseases. 139
Association Between Previously Identified Disease Loci At Chr12q15 and Chr1p36 and UC in Italian Population. 137
Early Post-Operative Endoscopic Recurrence in Crohn's Disease in an Italian Multicentric Cohort. 137
Clinical significante of NOD2/CARD15 and TLR4 gene SNPs in inflammatory bowel disease 137
Cytomegalovirus complicating Inflammatory Bowel Disease: Useful Remarks. 137
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy 137
Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre study 137
Urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels in patients with Crohn’s disease undergoing treatment with infliximab. 135
Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy. 134
Hepatocyte tight-junctional permeability is increased in rat experimental colitis. 133
Dysfunctional metacognitive beliefs and gastrointestinal disorders. Beyond an ‘organic’/‘functional’ categorization in the clinical practice. 133
Clinical practice in the management of ulcerative colitis - an Italian survey 132
Anti-TNF therapy in elderly people in IBD; an Italian multicentre survey 132
Mucosal Immunology and Probiotics. 132
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: The IG-IBD LIVE study 132
IBD-associated bone loss: is inflammation the explanation? 131
Gastric permeability to sucrose is increased in portal hypertensive gastropathy 130
Prevention of post-surgical recurrence with adalimumab in a patient with complicated Crohn's disease. 130
Metacognition and negative emotions in clinical practice. A preliminary study with patients with bowel disorder 130
GASTROINTESTINAL PERMEABILITY IS INCRISED IN SCLERODERMA PATIENTS 129
Vitamin D and inflammatory bowel disease 129
Infliximab normalizes intestinal permeability in the short-term but not fecal calprotectin in Crohn’s disease 128
Efficacy and safety of long-term infliximab use for Crohn’s disease in Southern Italy. 128
Hongos productores de biopelículas como causa emergente de infecciones por vía hemática en la enfermedad inflamatoria intestinal 128
Thalidomide for refractory bleeding small intestinal Crohn’s disease– a case report 127
Ileal tight junction (TJ) alterations associated with experimental colitis – a time course. 127
Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis 126
Acute onset of Lupus associated Pancreatitis Mimicking Pancreatic Cancer 125
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in southern Italy 125
Serology of Viral Infections and Tuberculosis Screening in an IBD Population Referred to a Tertiary Centre of Southern Italy 125
Infliximab and etanercept are equally effective in reducing enterocyte apoptosis in experimental colitis. 124
Experimental colitis increases small intestine permeability in the rat 123
Contenuti metacognitivi e alessitimia in un gruppo di soggetti con disturbi gastrointestinali. Uno studio esplorativo 123
Sealing The Broken Barrier in IBD: Intestinal Permeability, Epithelial Cells and Junctions. 123
Gastro-intestinal permeability is increased in patients with limited systemic sclerosis 121
Comment to "Management of cytomegalovirus infection in inflammatory bowel diseases" 121
Efficacy and safety of long-term infliximab use for Crohn’s disease in Southern Italy. 120
Gastric fundectomy in the rat - effects on mineral bone metabolism, with emphasis on the gastrin-calcitonin-parathyroid hormone-vitamin D axis 119
Predicting response to thiopurines – a single centre experience. 119
Quality of Life (QoL) in Patients with Chronic Inflammatory Bowel Diseases: How Much Better with Biological Drugs? 118
Therapy-related adverse events in Crohn’s disease (CD) – a comparison between thiopurines, infliximab and combined therapy. 118
Treatment of life threatening type I refractory celiac disease with long term infliximab 116
Osteopenia following total gastrectomy in the rat - state of mineral metabolism and bone histomorphometry 115
A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis 115
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial 115
Thiopurines in the treatment of inflammatory bowel diseases – a single centre experience. 114
Inflammatory Bowel Disease in the Elderly – Knowledge Gaps and Potential Directions in Research 114
Effects of anti COX-2, nabumetone and aspirin on gastric and intestinal permeability on healthy volunteers 113
A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease 110
Quality of life after proctocolectomy and ileo-anal anastomosis for severe ulcerative colitis 110
Extra-gastric effects of highly selective vagotomy. Bone and mineral metabolism in the rat. 110
Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study 109
Microradiographic anatomy of the explanted rat colon 108
Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. 106
Totale 14.002
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.543
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021349 0 0 0 0 0 0 0 0 0 156 107 86
2021/20221.422 8 191 30 42 45 15 62 46 15 337 196 435
2022/20233.433 304 280 156 303 288 323 39 178 1.418 17 91 36
2023/2024798 70 117 88 133 89 103 21 30 2 69 8 68
2024/20254.406 64 56 129 233 255 199 147 886 1.123 228 341 745
2025/202611.657 470 775 871 756 984 2.734 1.548 1.597 1.506 416 0 0
Totale 25.739